Clinical Trial

First-In-Human Study in Participants With Advanced Solid Tumors

Name: First-In-Human Study in Participants With Advanced Solid Tumors — clinical trial record (NCT06885645)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1 Study of KH815 for Injection to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity in Patients with Advanced Solid Tumors

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-13.

Trial Details

NCT Number	NCT06885645
Lead Sponsor	Chengdu Kanghong Biotech Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	30 participants
Start Date	2025-04-30
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-03